With regard to South Korea, Novartis solved sure effectively-publicized allegations that it had made poor payments to HCPs in South Korea by means of spherical tables and third-bash health-related journals. Novartis Korea allegedly transmitted incorrect honoraria to HCPs for round tables through health-related journals to avoid compliance scrutiny,